DR. STEVEN MINTER D.O. NPI 1649431990

NPI Details

DR. Steven Minter, D.O. is an internal medicine in Columbia, SC with 19 years of experience. The provider is a physician who provides long-term, comprehensive care in the office and the hospital, managing both common and complex illness of adolescents, adults and the elderly. Internists are trained in the diagnosis and treatment of cancer, infections and diseases affecting the heart, blood, kidneys, joints and digestive, respiratory and vascular systems. They are also trained in the essentials of primary care internal medicine, which incorporates an understanding of disease prevention, wellness, substance abuse, mental health and effective treatment of common problems of the eyes, ears, skin, nervous system and reproductive organs. DR. Steven Minter, D.O. NPI is 1649431990. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

166 STONERIDGE DR
COLUMBIA, SC
ZIP 29210-239
Phone: (803) 461-3000

The NPI 1649431990 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, ferric carboxymaltose, 1 mg (HCPCS:J1439)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml (HCPCS:Q9967)
• Injection, pembrolizumab, 1 mg (HCPCS:J9271)
• Injection, oxaliplatin, 0.5 mg (HCPCS:J9263)
• Injection, granisetron, extended-release, 0.1 mg (HCPCS:J1627)
• Injection, aprepitant, 1 mg (HCPCS:J0185)
• Injection, daratumumab, 10 mg and hyaluronidase-fihj (HCPCS:J9144)
• Injection, gadobutrol, 0.1 ml (HCPCS:A9585)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg (HCPCS:J1568)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Injection, bortezomib (velcade), 0.1 mg (HCPCS:J9041)
• Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
• Liver function blood test panel (HCPCS:80076)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Injection, leucovorin calcium, per 50 mg (HCPCS:J0640)
• Injection, pegfilgrastim, excludes biosimilar, 0.5 mg (HCPCS:J2506)
• Injection, fluorouracil, 500 mg (HCPCS:J9190)
• Infusion into a vein for hydration, each additional hour (HCPCS:96361)
• Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
• Flow cytometry technique for dna or cell analysis, each additional marker (HCPCS:88185)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Gammaglobulin (immune system protein) measurement (HCPCS:82784)
• Cyclophosphamide, 100 mg (HCPCS:J9070)
• Ferritin (blood protein) level (HCPCS:82728)
• Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
• Injection, carboplatin, 50 mg (HCPCS:J9045)
• Red blood count, manual test (HCPCS:85044)
• Iron level (HCPCS:83540)
• Iron binding capacity (HCPCS:83550)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Ct scan of chest with contrast (HCPCS:71260)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Ct scan of abdomen and pelvis with contrast (HCPCS:74177)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l (HCPCS:G0498)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
• Unclassified drugs (HCPCS:J3490)
• Application of on-body injector for under skin injection (HCPCS:96377)
• Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
• Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
• Total protein level, urine (HCPCS:84156)
• Ct scan of chest without contrast (HCPCS:71250)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries (HCPCS:A9552)
• Dxa bone density measurement of hip, pelvis, spine (HCPCS:77080)
• Initial hospital inpatient care per day, typically 50 minutes (HCPCS:99222)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Nuclear medicine study from skull base to mid-thigh with ct scan (HCPCS:78815)
• Influenza vaccine split virus, preservative free (HCPCS:90662)
• X-ray of chest, 2 views (HCPCS:71046)
• 5% dextrose/water (500 ml = 1 unit) (HCPCS:J7060)
• Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion (HCPCS:96368)
• Folic acid level, serum (HCPCS:82746)
• Mri scan of brain before and after contrast (HCPCS:70553)
• Complete x-ray of body bones (HCPCS:77075)
• Flow cytometry technique for dna or cell analysis, first marker (HCPCS:88184)
• Ct scan of abdomen and pelvis without contrast (HCPCS:74176)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
• Ct scan of abdomen with contrast (HCPCS:74160)
• Magnesium level (HCPCS:83735)
• Biopsy and aspiration of bone marrow sample for diagnosis (HCPCS:38222)
• Mri scan of abdomen before and after contrast (HCPCS:74183)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Infusion, normal saline solution, 250 cc (HCPCS:J7050)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Nuclear medicine study whole body with ct scan (HCPCS:78816)

The enumeration date for this NPI number is 6/19/2008 and was last updated on 11/1/2018.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available: